CT
VRTX icon

Clearstead Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Clearstead Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.6K Sell
116
-45
-28% -$19.9K 0.01% 311
2026
Q1 		$71.9K Hold
161
– – 0.01% 275
2025
Q4 		$73K Buy
161
+29
+22% +$12.5K 0.01% 289
2025
Q3 		$51.7K Sell
132
-41
-24% -$17.1K 0.01% 310
2025
Q2 		$77K Buy
173
+9
+5% +$4.15K 0.01% 271
2025
Q1 		$79.5K Sell
164
-70
-30% -$32.6K 0.02% 229
2024
Q4 		$94.2K Buy
234
+97
+71% +$45K 0.02% 210
2024
Q3 		$63.7K Hold
137
– – 0.02% 222
2024
Q2 		$64.2K Hold
137
– – 0.02% 219
2024
Q1 		$57.3K Buy
137
+70
+104% +$29.6K 0.02% 232
2023
Q4 		$27.3K Sell
67
-30
-31% -$11.1K 0.01% 272
2023
Q3 		$33.7K Buy
97
+30
+45% +$10.5K 0.01% 247
2023
Q2 		$21.1K Hold
67
– – 0.01% 268
2023
Q1 		$21.1K Hold
67
– – 0.01% 262
2022
Q4 		$19K Hold
67
– – 0.01% 284
2022
Q3 		$19K Hold
67
– – 0.01% 261
2022
Q2 		$19K Hold
67
– – 0.01% 137
2022
Q1 		$17K Buy
+67
New +$15.9K 0.01% 145
2021
Q4 		– Sell
-10,459
Closed -$1.9M – 197
2021
Q3 		$1.9M Sell
10,459
-294
-3% -$57.4K 1.2% 25
2021
Q2 		$2.34M Sell
10,753
-735
-6% -$154K 1.53% 23
2021
Q1 		$2.47M Buy
11,488
+554
+5% +$122K 1.83% 20
2020
Q4 		$2.58M Buy
+10,934
New +$2.51M 1.54% 23
2017
Q3 		– Sell
-375
Closed -$48K – 235
2017
Q2 		$48K Buy
+375
New +$45.1K 0.04% 160

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clearstead Trust's VRTX Position: Q2 2026 in Review

Clearstead Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 28% in Q2 2026, selling an estimated $19.9K and leaving 116 shares worth $57.6K. The position accounts for 0.01% of the portfolio, ranked #311.

Clearstead Trust first reported a position in VRTX in Q2 2017 and has held it in 23 quarters since. The position peaked at $2.58M in Q4 2020. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Clearstead Trust held 116 shares of Vertex Pharmaceuticals worth $57.6K as of Q2 2026.
  • Clearstead Trust sold 45 Vertex Pharmaceuticals shares in Q2 2026, an estimated $19.9K.
  • Vertex Pharmaceuticals made up 0.01% of Clearstead Trust's portfolio in Q2 2026, its #311 holding.
  • Clearstead Trust first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 23 quarters since.
  • Clearstead Trust's Vertex Pharmaceuticals position peaked at $2.58M in Q4 2020.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.